Albion Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $72.9K | Hold |
577
| – | – | ﹤0.01% | 253 |
|
|
2026
Q1 | $80.4K | Hold |
577
| – | – | 0.01% | 232 |
|
|
2025
Q4 | $70.8K | Hold |
577
| – | – | ﹤0.01% | 228 |
|
|
2025
Q3 | $64K | Hold |
577
| – | – | ﹤0.01% | 239 |
|
|
2025
Q2 | $64K | Sell |
577
-103
| -15% | -$11K | ﹤0.01% | 226 |
|
|
2025
Q1 | $76.2K | Sell |
680
-103
| -13% | -$10.6K | 0.01% | 217 |
|
|
2024
Q4 | $72.3K | Buy |
783
+506
| +183% | +$45.6K | ﹤0.01% | 226 |
|
|
2024
Q3 | $23.2K | Hold |
277
| – | – | ﹤0.01% | 287 |
|
|
2024
Q2 | $19K | Hold |
277
| – | – | ﹤0.01% | 298 |
|
|
2024
Q1 | $20.3K | Hold |
277
| – | – | ﹤0.01% | 276 |
|
|
2023
Q4 | $22.4K | Hold |
277
| – | – | ﹤0.01% | 263 |
|
|
2023
Q3 | $20.8K | Hold |
277
| – | – | ﹤0.01% | 259 |
|
|
2023
Q2 | $21.3K | Hold |
277
| – | – | ﹤0.01% | 267 |
|
|
2023
Q1 | $23K | Hold |
277
| – | – | ﹤0.01% | 255 |
|
|
2022
Q4 | $23.8K | Hold |
277
| – | – | ﹤0.01% | 250 |
|
|
2022
Q3 | $17K | Hold |
277
| – | – | ﹤0.01% | 271 |
|
|
2022
Q2 | $17K | Hold |
277
| – | – | ﹤0.01% | 281 |
|
|
2022
Q1 | $16K | Hold |
277
| – | – | ﹤0.01% | 333 |
|
|
2021
Q4 | $20K | Sell |
277
-122
| -31% | -$8.4K | ﹤0.01% | 353 |
|
|
2021
Q3 | $28K | Hold |
399
| – | – | ﹤0.01% | 297 |
|
|
2021
Q2 | $27K | Buy |
+399
| New | +$26.6K | ﹤0.01% | 306 |
|
|
2020
Q4 | $495K | Sell |
8,499
-1,849
| -18% | -$112K | 0.05% | 142 |
|
|
2020
Q3 | $654K | Hold |
10,348
| – | – | 0.07% | 135 |
|
|
2020
Q2 | $796K | Buy |
10,348
+1,800
| +21% | +$138K | 0.09% | 109 |
|
|
2020
Q1 | $639K | Buy |
8,548
+1,837
| +27% | +$127K | 0.09% | 109 |
|
|
2019
Q4 | $436K | Hold |
6,711
| – | – | 0.05% | 150 |
|
|
2019
Q3 | $425K | Hold |
6,711
| – | – | 0.05% | 150 |
|
|
2019
Q2 | $453K | Hold |
6,711
| – | – | 0.06% | 151 |
|
|
2019
Q1 | $436K | Hold |
6,711
| – | – | 0.06% | 151 |
|
|
2018
Q4 | $420K | Hold |
6,711
| – | – | 0.07% | 143 |
|
|
2018
Q3 | $518K | Hold |
6,711
| – | – | 0.07% | 137 |
|
|
2018
Q2 | $475K | Hold |
6,711
| – | – | 0.07% | 138 |
|
|
2018
Q1 | $506K | Sell |
6,711
-93
| -1% | -$7.39K | 0.08% | 129 |
|
|
2017
Q4 | $487K | Buy |
6,804
+48
| +0.7% | +$3.65K | 0.07% | 128 |
|
|
2017
Q3 | $547K | Hold |
6,756
| – | – | 0.08% | 124 |
|
|
2017
Q2 | $478K | Hold |
6,756
| – | – | 0.08% | 128 |
|
|
2017
Q1 | $459K | Sell |
6,756
-243
| -3% | -$17.1K | 0.07% | 132 |
|
|
2016
Q4 | $501K | Buy |
6,999
+228
| +3% | +$16.9K | 0.08% | 116 |
|
|
2016
Q3 | $536K | Buy |
6,771
+43
| +0.6% | +$3.49K | 0.09% | 118 |
|
|
2016
Q2 | $561K | Hold |
6,728
| – | – | 0.1% | 104 |
|
|
2016
Q1 | $618K | Sell |
6,728
-80,583
| -92% | -$7.27M | 0.1% | 106 |
|
|
2015
Q4 | $8.84M | Buy |
87,311
+92
| +0.1% | +$9.57K | 1.52% | 18 |
|
|
2015
Q3 | $8.56M | Buy |
87,219
+1,167
| +1% | +$130K | 1.55% | 18 |
|
|
2015
Q2 | $10.1M | Buy |
86,052
+279
| +0.3% | +$30.5K | 1.67% | 17 |
|
|
2015
Q1 | $8.42M | Sell |
85,773
-141
| -0.2% | -$14.3K | 1.43% | 19 |
|
|
2014
Q4 | $8.1M | Sell |
85,914
-81,321
| -49% | -$8.41M | 1.4% | 21 |
|
|
2014
Q3 | $17.8M | Buy |
167,235
+1,055
| +0.6% | +$103K | 3.15% | 6 |
|
|
2014
Q2 | $13.8M | Buy |
166,180
+7,070
| +4% | +$550K | 2.39% | 8 |
|
|
2014
Q1 | $11.3M | Sell |
159,110
-26,919
| -14% | -$2.11M | 2.08% | 9 |
|
|
2013
Q4 | $14M | Buy |
186,029
+54,619
| +42% | +$3.8M | 2.62% | 7 |
|
|
2013
Q3 | $8.26M | Buy |
131,410
+4,493
| +4% | +$269K | 1.76% | 17 |
|
|
2013
Q2 | $6.51M | Buy |
+126,917
| New | +$6.62M | 1.45% | 23 |
|
Other funds holding GILD
Albion Financial Group's GILD Position: Q2 2026 in Review
Albion Financial Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 577 shares worth $72.9K. The position accounts for ﹤0.01% of the portfolio, ranked #253.
Albion Financial Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.8M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Albion Financial Group held 577 shares of Gilead Sciences worth $72.9K as of Q2 2026.
- Albion Financial Group left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #253 holding.
- Albion Financial Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Albion Financial Group's Gilead Sciences position peaked at $17.8M in Q3 2014.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.